Striatal dopamine receptor binding in morbidly obese women before and after gastric bypass surgery and its relationship with insulin sensitivity by Barbara A. de Weijer et al.
RESEARCH LETTER
Striatal dopamine receptor binding in morbidly obese women
before and after gastric bypass surgery and its relationship
with insulin sensitivity
Barbara A. de Weijer & Elsmarieke van de Giessen & Ignace Janssen &
Frits J. Berends & Arnold van de Laar & Mariette T. Ackermans &
Eric Fliers & Susanne E. la Fleur & Jan Booij & Mireille J. Serlie
Received: 26 September 2013 /Accepted: 7 January 2014 /Published online: 6 February 2014
# The Author(s) 2014. This article is published with open access at Springerlink.com
Keywords Dopamine receptor . Gastric bypass surgery .
Insulin sensitivity . Obesity . SPECT . Striatal dopamine .
Weight loss
Abbreviations
BPND Non-displaceable binding potential
D2/3R Dopamine D2/3 receptor
fMRI Functional magnetic resonance imaging
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RYGB Roux-en-Y gastric bypass surgery
SPECT Single photon emission computed tomography
To the Editor : There is evidence that certain brain areas are
functionally altered in obesity. In obese humans, we and
others have reported a reduction in dopamine D2/3 receptor
(D2/3R) binding in the striatum, an important component of
the brain reward system [1–3]. The neurotransmitter dopa-
mine is important for the reinforcing value of food and it has
been shown that food can induce a release of endogenous
dopamine in the striatum [4]. Obese individuals are thought to
be more sensitive to food reinforcement than those who are
non-obese. This may underlie the notion that obese humans
experience an increased craving for food. In addition, striatal
D2/3R availability has been linked to craving and diet-
induced obesity [5]. Therefore, it is plausible that dopamine-
related mechanisms linked to craving and impulsiveness play
a role in the development and pathophysiology of obesity. At
present, it is unclear whether lower D2/3R availability is a
cause or an effect of obesity. If the latter is true, one would
expect that the reduced D2/3R availability observed in obese
humans is reversed following the loss of a clinically signifi-
cant fat mass or during a hypoenergetic state.
Obesity is associated with insulin resistance. Insulin recep-
tors are widely expressed in the human brain, and a relation-
ship between insulin sensitivity and central dopamine signal-
ling has been suggested [6]. It needs to be determined, there-
fore, whether the striatal D2/3R binding potential correlates
with hepatic or peripheral insulin sensitivity.
To determine whether the previously reported reduction in
D2/3R availability in obese humans is reversible, we studied
striatal D2/3R availability before and 6 weeks after Roux-en-
Y gastric bypass (RYGB) surgery in 19 morbidly obese wom-
en. Eighteen of these patients participated in a study on the
short-term metabolic effects of RYGB surgery (NTR1548; for
one additional patient only single photon emission computed
tomography [SPECT] data could be acquired) [3]. Informed
consent was obtained from all participants and the study was
approved by the local medical ethics committee of the
Academic Medical Center in Amsterdam. We assumed that a
difference of 15% in D2/3R availability would be of clinical
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relevance. A power analysis indicated that we would be able
to detect this difference in a study group of 18 individuals. In
the morbidly obese women, striatal D2/3R availability was
assessed using a brain-dedicated SPECT scanner and
[123I]iodobenzamide (bolus/constant infusion technique).
Acquisition, attenuation correction, reconstruction and analy-
ses of SPECT data were performed as previously described
[1]. Apart from a classic region-of-interest (ROI) analysis,
data also underwent anMRI-driven analysis. In this additional
analysis, SPECT images were co-registered to individual MR
images, and ROIs were drawn for the caudate nucleus and
putamen separately and for the occipital cortex (representing
non-specific binding) on the MR images [7]. Insulin
sensitivity was determined before surgery by a two-step
hyperinsulinaemic–euglycaemic clamp using a stable glucose
isotope tracer [8]. Data for four women were not complete
owing to technical failures and were excluded from analysis.
The women had a mean age of 40.4±8 (26–49) years
(mean ± SD [range]). Weight loss 6 weeks after RYGB was
14±4.6 (8–24)kg, which resulted in a significant reduction in
BMI after surgery (before surgery 45.7±6.3 [38.7–61.3] and
after surgery 40.9±6.3 [34.1–57.6] kg/m2; p< 0.001). The
ROI analysis showed no significant change in D2/3R avail-
ability before vs 6 weeks after RYGB (Fig. 1a). Also, in the
MRI-driven analysis, the D2/3R availability in the striatum as
a whole and in subregions of the striatum (caudate nucleus and
putamen) did not change significantly after surgery (Fig. 1b).
There was no correlation between BMI and D2/3R availability
before (p= 0.35; r2=0.054) or after surgery (p= 0.51;
r2=0.027). This suggests that striatal D2/3R is not regulated
by acute changes in energy balance and is not influenced by
fat mass per se.
Earlier studies on D2/3R binding after bariatric surgery are
contradictory and report either an increase [2] or a decrease [3]
in striatal D2/3R availability 6 weeks after surgery. Whether a
change in D2/3R occurs after long-term weight loss is un-
known. Interestingly, when correlating the pre-surgery level of
peripheral insulin sensitivity with pre-surgery striatal
D2/3R binding availability, a trend for a positive correlation
was observed (Fig. 1c), but there was no correlation with
hepatic insulin sensitivity. The former is in line with the
general insulin-sensitising effects of dopamine agonists in
obese diabetic individuals. In addition, dopamine antagonists
are known for their negative effects on insulin sensitivity, and
drug-naive schizophrenic patients, known for their disturbed
central dopamine metabolism, are characterised by hepatic
insulin resistance [9]. Furthermore, a correlation between the
insulin sensitivity index (SI) and D2/3R availability in the
ventral striatum has been reported [10]. This suggests that
peripheral glucose uptake, predominantly occurring in skele-
tal muscle when under hyperinsulinaemic conditions, might
be in part regulated by cerebral dopamine metabolism.
Although a clear difference in D2/3R availability was found
between lean and obese individuals [2], within our obese
group no clear correlation between BMI and D2/3R availabil-
ity was found. This suggests that fat mass per se is not the
main determinant of D2/3R availability in obesity. This is in
line with the unchanged D2/3R availability, despite clinically
significant weight loss. Our study is limited to women only
and a potential bias of the menstrual cycle on our outcome
cannot be excluded.
In conclusion, surgery-induced weight loss does not sig-
nificantly increase striatal D2/3R availability in morbidly
obese women. This suggests that short-term changes in energy
balance in morbidly obese humans do not induce profound
alterations in striatal dopaminergic neurotransmission and
might predispose obese individuals to regain weight after a
hypoenergetic diet. Moreover, the striatal dopamine receptor
binding potential is not significantly correlated to hepatic
insulin sensitivity but shows a trend for a positive correlation
with peripheral insulin sensitivity. This adds to earlier findings
on a potential role for cerebral dopamine in glucose
metabolism.
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Fig. 1 Striatal D2/3R availability of 18 obese women before and 6 weeks
after bariatric surgery according to (a) classic ROI analysis (without MRI
co-registration), mean BPND before vs after surgery (p= 0.415); (b)
boxplots showing MRI-driven analysis expressed for the whole striatum
as well as striatal subregions (caudate, p= 0.272; putamen, p=0.661;
striatum p=0.842, before vs after surgery). White bars represent BPND
before RYGB, grey bars represent BPND after RYGB. (c) Striatal D2/3R
availability of 16 obese women before bariatric surgery vs insulin-medi-
ated rate of peripheral glucose disappearance (Rd) (r2 = 0.156; p=0.14)
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